Targeting the Undruggable Proteome: The Small Molecules of My Dreams
- 24 June 2010
- journal article
- review article
- Published by Elsevier BV in Cell Chemical Biology
- Vol. 17 (6), 551-555
- https://doi.org/10.1016/j.chembiol.2010.05.011
Abstract
No abstract availableThis publication has 46 references indexed in Scilit:
- Protein Knockdown Using Methyl Bestatin−Ligand Hybrid Molecules: Design and Synthesis of Inducers of Ubiquitination-Mediated Degradation of Cellular Retinoic Acid-Binding ProteinsJournal of the American Chemical Society, 2010
- Chemical Genetic Control of Protein Levels: Selective in Vivo Targeted DegradationJournal of the American Chemical Society, 2004
- Development of Protacs to Target Cancer-promoting Proteins for Ubiquitination and DegradationMolecular & Cellular Proteomics, 2003
- Dissecting Temporal and Spatial Control of Cytokinesis with a Myosin II InhibitorScience, 2003
- JNK and ERK signaling pathways in multistage mouse carcinogenesis: studies in the inhibition of signaling cascades as a means to understand their in vivo biological role.2002
- The emerging power of chemical geneticsCurrent Opinion in Cell Biology, 2002
- 2 Discovery of Cep-1347/Kt-7515, an Inhibitor of the Jnk/Sapk Pathway for the Treatment of Neurodegenerative DiseasesProgress in Medicinal Chemistry, 2002
- Eg5 is static in bipolar spindles relative to tubulinThe Journal of cell biology, 2001
- Histone deacetylase as a new target for cancer chemotherapyCancer Chemotherapy and Pharmacology, 2001
- Small Molecule Inhibitor of Mitotic Spindle Bipolarity Identified in a Phenotype-Based ScreenScience, 1999